Discover IceCure Breast Cryoablation at ECIO 2026: Join us at the European Conference on Interventional Oncology in Basel
Join IceCure at the European Conference on Interventional Oncology (ECIO) in Basel, Switzerland from April 26 – 30. Discover how our liquid nitrogen-based ProSense™ Cryoablation system is giving clinicians new choices in interventional oncology at Booth #4. IceCure is proud to be a silver sponsor at ECIO 2026, one of the leading global meetings dedicated to minimally invasive image-guided cancer […]
IceCure at SBI 2026 Symposium: Discover ProSense® Cryoablation for Breast Tumors
Visit us at Booth 817 during the SBI Breast Imaging Symposium to explore cryoablation for low-risk breast cancers and fibroadenoma.
IceCure to Exhibit and Join the Hands-on Cryoablation Sessions at the European Conference on Interventional Oncology (ECIO) 2025
IceCure Medical is excited to be a Silver Sponsor at the European Conference on Interventional Oncology (ECIO) 2025. The conference is taking place from April 13 – April 16, in Rotterdam, Netherlands. Visit IceCure at Booth 17 for the opportunity to learn about our advanced liquid nitrogen cryoablation technology, the ProSense™ System. ProSense™ Cryoablation at […]
Cryoablation Allows the Ultimate De-escalation of Surgical Therapy for Select Breast Cancer Patients
A study showing that cryoablation allows the ultimate de-escalation of surgical therapy for select breast cancer patients.
Assessing the Outcome of Cryoablation Treatment on Different Molecular Subtypes of Low-Grade Breast Cancer
Study assessing the outcome of cryoablation treatment on different molecular subtypes of low-grade breast cancer.
Cryoablation of Primary Breast Cancer in Patients Ineligible for Clinical Trials: A Multiinstitutional Study
Study on the cryoablation of primary breast cancer in patients ineligible for clinical trials: a multi-institutional study.
Cryoablation Therapy for Early-Stage Breast Cancer: Evidence and Rationale
This publication provides a comprehensive evaluation of cryoablation as a non-surgical alternative to traditional breast-conserving surgery for early-stage breast cancer.
Percutaneous Ultrasound-Guided Cryoablation for Early-Stage Primary Breast Cancer: A Follow-Up Study in Japan
The study investigates the long-term outcomes of percutaneous cryoablation (PCA) as a minimally invasive treatment for early-stage breast cancer (ESBC).
Cryoablation Eases Pain for Terror Victim
Cryoablation, the process of destroying tissue with ultra-low freezing temperatures, is being used around the world to treat a growing number of clinical indications. In many cases, the driving force behind a novel use of cryoablation is driven not by researchers or physicians, but by the patients themselves. In this blog, we highlight the case […]
A step forward towards cryoablation for early-stage breast cancer: Final 5-year results of the ICE3 trial
Researchers are consistently pushing back the boundaries of what is possible for the treatment of breast cancer. Results of one of the most exciting and innovative trials in breast cancer, the ICE3 Trial on cryoablation of early stage, low-risk breast cancer, were recently published in the Annals of Surgical Oncology by Dr. Richard Fine. In […]